*with a 12-mo subscription. Pay upfront in full. Actual price to customer will depend on product and subscription plan purchase. Compounded semaglutide, including Hims & Hers’ product (pictured above), is not approved or evaluated for safety, efficacy, or quality by FDA. Wegovy® (semaglutide) and Ozempic® (semaglutide) are not compounded. Wegovy® (semaglutide) is FDA-approved for weight loss. Ozempic® (semaglutide) is FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider’s discretion. A healthcare provider may prescribe a compounded drug if determined that it is medically appropriate and necessary for you.